Latest filing published 24 Jul 2026 for Heramed Limited.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Timothy Chapman: trading record in brief
All filings by Timothy Chapman on record concern Heramed Limited, in the capacity of senior executive. We count 3 filings; the first trade dates from 21 April 2026 and the latest from 20 July 2026.
On the open market, the record shows 2 purchases and 1 sale. No amount is published for 3 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 24 July 2026 with an open-market sale in Heramed Limited. The most recent open-market purchase was published on 15 June 2026, 146 days ago. Typically, a trade is published a median of 6 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Timothy Chapman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,666,666 sharesShareASXISIN AU0000028367ASX:2924-03114023-2A1685796
- 3,500,000 sharesShareASXASX:2924-03100312-2A1677447Canonical exit: 7 Sept 2026 (T+90)
- 2,500,000 sharesShareASXISIN AU0000028367ASX:2924-03082745-2A1668366Canonical exit: 20 Jul 2026 (T+90)
3 of 3 declarations